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Background: The unnecessary and unsafe use of injections is common in developing countries like Nepal.
Policymakers have an important role in promoting rational and safe injection use. Hence, the present study was
carried out to explore the perception of health policymakers regarding safe injection practice in Nepal.
Methods: An exploratory qualitative study design was used in this study. Key policymakers from both the central
and regional level were selected using purposive sampling. A semi-structured questionnaire advocated by the
World Health Organization (WHO) was used after modifying the context. Interviews were conducted to clarify doubts
and obtain additional information. The data was analyzed manually using deductive content analysis technique.
Results: In total, eleven policymakers participated. All unanimously agreed that injection safety is a problem and seven
participants reported that injections are overused. They shared the opinion that injections are administered by various
providers, including formal and informal health providers, and also quacks. Almost half the respondents reported that
the National Drug Policy discourages injection overuse, while others reported that the policy contains no provisions
regarding injection overuse. Most policymakers stated that only single-use disposable injection equipment is used to
provide injection, while others thought that sterilizable glass syringe is also used. More than half of the participants
believed that the quality of injection equipment available in the Nepalese market is not regulated by any government
institution. Almost two-third of the policymakers stated that syringes and needles are not reused, while the rest
thought syringes might be reused without sterilization in some parts of the country. Almost half of the respondents
stated that illegal commercialization of used syringes exists in Nepal. Almost all respondents thought that health care
institutions have a waste management plan, while more than half of them opined that such plans are limited to tertiary
care hospitals located in the capital.
Conclusions: The result of this study revealed a divergence of views among policymakers, even among those in
the same ministry. Though there has been some effort from the government to increase the safety of injection
practices, greater efforts are required, especially with regard to standardization of policies and procedures related to
injection practice.
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Country overview
Nepal is a small landlocked country in South Asia, sand-
wiched between the two giant countries of India and
China with a population of 26.5 million [1]. It ranks as
one of the poorest countries in the world, with a per capita
income of US $717 [1]. For administrative purposes,* Correspondence: sudeshgy@hotmail.com
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unless otherwise stated.Nepal is divided into 5 development regions, 14 zones and
75 districts [1]. The government of Nepal administers
health care services through the Ministry of Health and
Population (MoHP). MoHP delivers preventive, promo-
tional and curative health services through the Depart-
ment of Health Services (DoHS). In each development
region of Nepal, there is a regional health directorate and
in each district, there is a public health office. In Nepal,
the government provides health care services through
outreach clinics, female community health volunteers,
primary health care facilities [Sub Health Posts (SHP),l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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and other hospitals (district, zonal, regional and central).
Apart from this, the ministry also controls, monitors and
supervises health care services provided by the non-
governmental sector [2,3]. The regional health directorates
and district public health offices, under the supervision of
the MoHP, have the responsibility of monitoring, control-
ling and ensuring the delivery of health services to people
under their jurisdiction [2].
Although Nepal is divided into different administrative
units, most of the administrative power is centralized.
Hence, most important policies and plans for the country
are implemented and regulated centrally from the Ministry
level [4]. Following a decade long violent conflict in the
country that lasted almost two decades, currently the
country is passing through political transition and a debate
on state restructuring and administrative reform is ongoing
in the Constituent Assembly [5].
Injection use
Injection is an important health care procedure. People
receive (use) injections from the beginning of life as a
vaccine (immunization purpose) and may use them till
the last day of life (curative purpose). Every year billions
of injections are used worldwide and most (>95%) are
used for therapeutic purposes [6]. Even though injection
use is a global phenomenon, its overuse in developing
countries is very common [7]. There are various factors
that make injections popular in developing countries.
Some of these factors are [8-10]:
1. Lack of adequate knowledge of prescribers about
rational use of injections
2. Demand for injections by patients because they
perceive injections to be more powerful than oral
formulations
3. Economic benefits to the injection providers
4. Weak policy and laws regulating injection practice.
A survey conducted to estimate worldwide injection
use frequency (per person per year) showed that injection
use in the Southeast Asia region D (which includes Nepal)
was high and most injections used were neither necessary
nor safe [11]. A large number of injections in the region
were provided in an unsafe manner by unqualified per-
sonnel [7] reusing injection equipment without proper
sterilization [11]. The reuse of injection equipment
without sterilization was as high as 75% (ranging from
60%-88%) in the Southeast Asia region D [11].
Safe and unsafe injection practices
A safe injection “does no harm to the recipient, does not
expose the health worker to any risk and does not result
in waste that is dangerous for the community” [6]. Sterileinjection practice by qualified personnel ensures the safety
of the injection recipient. Proper sharp waste collection
and effective protection (including vaccination against
hepatitis B) ensures the safety of the provider. Appro-
priate sharp waste disposal ensures the safety of the
community [6].
Safe and rational use of injections could save lives, but
the same injections used unsafely and excessively may
also threaten life by transmitting diseases and causing
complications. The transmission of Hepatitis B virus
(HBV), Hepatitis C virus (HCV), and Human Immuno-
deficiency virus (HIV) infections through unsafe injec-
tions is of particular concern [10]. It was estimated by
the WHO that in the year 2008, unsafe medical injections
caused 15 million, 1 million and 0.34 million cases of
HBV, HCV and HIV infections, respectively [12]. Unsafe
disposal of injection equipment not only increases the risk
of scavenging and commercialization (resale) of the used
equipment, but also may lead to needle-stick injuries
(NSIs) among health care workers and waste handlers.
NSIs may transmit blood-borne infections including HIV,
HBV and HCV [10]. In addition to the morbidity and
mortality associated with blood-borne infections, unsafe
injection practices exert a heavy indirect economic burden
on society which may not be properly accounted for.
Hence, it is imperative to ensure safe injection practice in
poor developing countries like Nepal.
There is a paucity of studies on injection practice in
Nepal. Certain studies [13,14] suggest that injection prac-
tices were unsafe, administration of unnecessary injections
was common and disposal of injection equipment was
poor in Nepal. A study conducted in a few government
primary health care facilities [15] indicated that the Gov-
ernment of Nepal has taken certain initiatives to promote
safe injections [3]. Use of auto-disable syringes for child
immunizations, safety boxes for disposal of used sy-
ringes, recommendations for the safe disposal of filled
safety-boxes, and abandoning recapping of used syrin-
ges are some of the initiatives taken for safe injection
practices [3,15].
The country is in transformation and restructuring of
the state and promulgation of a new constitution has
been long awaited [5]. The 2007 interim constitution, has
guaranteed basic health care as a fundamental right of the
people of Nepal [3], which may be included in the new
constitution of the country. Furthermore, the 1991 Nepal
Health Policy has been recommended for revision [16].
Hence, major changes in the country’s health policies are
anticipated in the coming days. The perception of health
policymakers about safe injection practice has important
implications for regulation and control of injection prac-
tice in the country. Hence, this study was planned to
obtain information about the perception of health policy-
makers towards safe injection practice and the initiatives
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practice in Nepal.
Methods
An exploratory qualitative study was conducted during
June and July of 2012. Key informants from the Ministry
of Health and Population (MoHP), a Regional Health
Directorate and a District Health office were considered
for the study. A representative (head) of a NGO (non-
governmental organization) advocating safe injection
practices in Nepal also participated.
Sampling method
Purposive sampling was done to select the policymakers.
Eight policymakers from ministry level (various depart-
ments and divisions of MoHP), two from the regional
level, one from a district health office and one NGO
representative were selected. Eight policymakers from
the central level were selected with regard to conveni-
ence and time limitation. Furthermore, the policymakers
were the chiefs of their respective departments and the
number of policymakers selected was sufficient to include
all chiefs of departments or divisions of MoHP relating to
injection practice. The selected policymakers ranged from
the ranks of Secretary to under-secretary level in the
health bureaucracy. In the health bureaucracy of Nepal,
Secretary is the highest position. Under this person are
the 12th level officer, joint secretary, 11th level officer, and
under secretary (from highest to lowest) [17]. As the bur-
eaucratic structure of Nepal is centralized and most policy
matters are determined (controlled) centrally [4], more
policymakers from the ministry level were chosen.
While deciding on the number of participants the con-
cept of saturation of data which has an important role in
qualitative research was also used. At the central and
regional level the authors had the option of recruiting
more participants if data saturation was not achieved. By
the eighth interview with a central level policy maker
there was a repetition of data and the new information
produced minimal change to the themes and ideas already
confirmed by previous interviews. The interviews with
regional policymakers uncovered certain issues of import-
ance at a regional level and confirmed the data already
obtained from the central participants.
Study method
The data was collected using the questionnaire advocated
by the World Health Organization (WHO) to assess and
evaluate injection practices [18] after adapting to the local
context. For example, answers to questions were coded
based on the terminology used in Nepal for example
health care workers like health assistant (HA), community
medicine auxiliary (CMA), and professionalist which are
common. The sequence of the questions was modifiedand some questions, like “How many injections are there
in the National EDL?” were deleted from the list. The in-
strument contains standardized and open-ended questions
pertaining to injection practices (practices by injection
providers and interventions related to the control/preven-
tion of injection overuse), the reuse of injection equipment
(including measures to check the re-use of syringes) and
the disposal of injection-related waste.
The questionnaire was used to provide a broad frame-
work for the interview. The face to face individual inter-
views were conducted in the interviewees’ office during
working hours, for which prior appointments were
obtained. SG conducted the interviews under the guid-
ance of VKKC and with the help of people mentioned in
the acknowledgements. PRS was involved in the review of
literature and defining the different categories for coding
the responses. The interviews lasted for about 40-45
minutes and the policymakers did not agree with audio
recording the sessions. We could not schedule repeat in-
terviews with the policymakers due to their busy schedule.
The interviewer asked the questions as per the interview
guide. But, the respondents were asked about any add-
itional points they wanted to add regarding various topics
throughout the interview. The points mentioned were
noted and the draft notes were shown to the interviewees
after the interview. After the transcripts were ready, they
were also shared with the respondents.
Data analysis
The data was analyzed manually by three authors
(SG, MM and VKKC) using deductive content analysis
techniques [19,20]. The data obtained was coded using a
deductive approach where literature review and the WHO
questionnaire were used to develop categories and sub-
categories for coding and analysis. Each respondent’s
response was read several times to obtain a sense of the
whole and was compared with the notes taken during the
interview. Then, the contents were coded in accordance
with the predetermined categories [19,20]. Additional in-
formation provided by the interviewees was placed in a
new category, if required. Direct quotes were contex-
tualized, rendered readable and presented in the habitual
language of the interviewees.
Ethical issues
The study was approved by the Nepal Health Research
Council (NHRC), Kathmandu, Nepal on 17th May 2012
(Ref. No. 1233). The respondents were assured about the
confidentiality of information given and written, infor-
med consent was obtained.
Results
Out of 12 policymakers approached, 11 agreed to take
part in the study. One policymaker did not participate in
Gyawali et al. BMC International Health and Human Rights 2014, 14:21 Page 4 of 8
http://www.biomedcentral.com/1472-698X/14/21the study. All the participants were male. This corre-
sponds to the gender distribution in the higher echelons
of the health bureaucracy in Nepal [21].
Injection practice
The policymakers reported that injections are popular in
Nepal. Almost all policymakers stated that they were not
aware of statistics or studies that quantified the number
of syringes and needles sold or used annually in the
country. However, one participant quantified the volume
of sale of syringes in Nepal to be 15 million units per
annum. Almost two-thirds of participants shared that
injections in Nepal are administered by various providers
including not only formal and informal health providers
but also quacks. Rest of the participants stated that
injections are provided by the personnel from formal
and informal health systems only and one of them stated,
“… if others [other than formal sectors] are practicing then
that is illegal…” (Participant number 10, P-10).
Most respondents reported that injections are overused
in Nepal. The main reasons offered by them for this were:
i) Health care professionals and patients have an
impression that injections are more efficacious
and provide quicker relief than oral dosage forms
of medicine.
ii) The profits associated with injections lure health
care professionals to use them.
Almost half of the respondents reported that there is a
National Drug Policy that discourages injection overuse,
while others reported that there is no such provision in
the drug policy of Nepal. Only three respondents said
that one of the objectives of the drug Policy (1995) of
Nepal is to promote the rational use of medicines in
general and does not specifically concern itself with inject-
able medicines. Most policymakers stated that the essen-
tial drug list (EDL) and standard treatment schedule
(STS), have been revised to remove unnecessary injectable
medications.
Types of syringes used
The majority of policymakers stated that only single-use,
disposable injection equipment is used to provide injec-
tions, while others thought that sterilizable glass syringes
are also used sometimes. Half of the participants (all from
MoHP) shared that the quality of syringes and needles
available in the Nepalese market is not regulated by any
government institution. However, less than half the par-
ticipants said that monitoring may be carried out by the
Department of Drug Administration (DDA), and/or
the logistics management division of the Department
of Health Services (DoHS). One participant was not
aware about the quality controlling authority. Onlytwo policymakers from the central level said that there is
a plan to develop guidelines for the regulation of health
related products, which would cover surgical products
including, but not limited to, syringes and other injectable
equipment. One participant said, “Till now, there is no
Government institution to check the quality of the syringes
and needles imported or locally produced in our country.
But draft guidelines for regulation of Health Related Prod-
ucts, including needles and syringes, has been prepared”
(P-9). Similarly, another participant said that the issue of
quality of syringes will be addressed after implementation
of the guidelines (P-10). The NGO participant stated that
the Nepal Bureau of Standards and Metrology has framed
criteria for standardization of syringes, but these have not
yet been implemented. A photocopy of the standardiza-
tion booklet was shown to the interviewer.
Re-use and disposal of syringes
Almost two-thirds of the participants stated that syringes
and needles are not reused without sterilization, while the
rest mentioned that in very remote places and/or in the
Terai (flat plain) region of Nepal, syringes might be reused
without sterilization. One participant mentioned, “Yes, the
syringes are reused. It has been found during our field visits
that the used syringes have been collected from different
hospitals and sold to local scrap dealers. In some places,
local clinics have discovered the repacked, untreated syrin-
ges” (P-8).
All respondents shared that injection equipment, dilu-
ents and safety boxes are matched (supplied in the same
quantity) to the delivery of injectable drugs and vaccines
to government health facilities. Almost three-quarters of
respondents were of the opinion that even in the family
planning programme, injection equipment is matched to
deliveries of injectable contraceptives, while only two
respondents said that the equipment is not matched.
One of the respondents said that he did not know whether
the equipment was matched with deliveries of injectable
contraceptives or not. Almost two-thirds of the policy-
makers thought that a shortage of syringes and needles
contributes to unsafe injection practices.
Most policymakers were of the opinion that HIV/AIDS
prevention and care programs had communicated to the
general public and health care workers (HCWs), the risk
of HIV infection associated with injections. Almost half
the policymakers stated that commercialization (repack-
aging & re-selling) of used syringes exists in Nepal espe-
cially in the Terai region (bordering India), while others
said that they have no information about such commer-
cialization. One respondent said, “Syringes are being col-
lected by the scrap handlers to be recycled for plastic. There
might be potential for illegal repacking because the syringes
collected are not damaged and it can be reused (repacked)
after simple cleaning. ……… the plastic of syringe has high
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care” (P-8).
All respondents thought that the syringes and needles
are discarded in safety boxes immediately after use, but
a few of them had a reservation that the practice is
limited to only a few health care facilities. A repre-
sentative statement was, “Not in every hospital and
health centre the syringes and needle are appropriately
disposed” (P-7).
Most respondents believed that the used syringes are
disposed of properly in Nepal, while others believed that
the disposal is not satisfactory. Among those who believed
that the disposal of used syringes is satisfactory, a few
respondents believed that the safe disposal of used syrin-
ges is limited to central level hospitals and government
primary health facilities only. Almost all policymakers
thought that health care institutions have a waste manage-
ment plan, but more than half of them were of the opinion
that such plans are limited to only a few tertiary care hos-
pitals in the country’s capital. One of the policymakers
shared that the government of Nepal has been plan-
ning to extend the waste management system (imple-
mented only in a few government tertiary care hospitals)
to zonal hospitals in a few years. Only one policy-
maker said that health care services do not have a
waste management plan. Lack of manpower, training,
and monitoring systems, along with negligence and
budget constraints, were thought to be hindering factors
for such plans.
The respondents unanimously agreed that injection
safety is a problem in Nepal. Most policymakers shared
that negligence, lack of awareness about safe injection
practices and risks of unsafe injection practices were the
main factors responsible for unsafe injection practices.
Similarly, poverty, misconceptions about injection effi-
cacy, underestimation of the risks of unsafe injection
practices and advertisement of injections in dispensaries
were stated to be important factors contributing to un-
safe practices. Lack of injection practice skills among
HCWs was also mentioned by a few policymakers. One
participant stated, “Lack of… knowledge and skills [for
injection practice] among HCWs especially among newly
recruited employees cause unsafe injection practices”
(P-3). Similarly, another participant shared, “Allowing
patients and visitors to transfer used syringes e.g. blood
samples to the laboratory also contributes to unsafe prac-
tices” (P-11). In Nepal, health institutions (even tertiary
care hospitals) do not have a proper system to transfer
blood samples, especially those of admitted patients.
Nursing staff generally perform phlebotomy and direct
the patient’s attendant to carry the sample to the re-
spective laboratory for diagnostic tests. These samples are
sometime carried in a disposable syringe with a capped
needle.Discussion
The study explores the perception of policymakers about
injection practice in Nepal and initiatives taken by the
government for improving injection practice.
Types of injection providers
For analysis, the injection providers were classified into
formal, informal and quack sectors. The formal sector
includes doctors, nurses and other health care workers
who are qualified, trained and has legal rights to admin-
ister injections. The informal sector includes traditional
healers, medical dispensers (pharmaceutical personnel)
among others who are neither trained nor have legal
rights to administer injections. They are trained for other
health care services, e.g. medical dispensers are trained for
pharmacy practice but not for injection administration.
The informal sector has strong professional associations
and may have influence at the higher levels of govern-
ment, [9] while the quacks comprise of individuals who
are not formally identified by the state. The quacks are
either self-taught or learn the injection procedure by
observing it being carried out by another person. Almost
all policymakers shared that formal and informal health
providers both administer injections. Two-thirds of the
policymakers believed that quacks also administer injec-
tions to people in Nepal. Administration of injections by
unqualified personnel and quacks was also reported a few
years back in central Nepal [13]. Almost two-thirds of the
policymakers believed that injections were overused in
Nepal. Both overuse and administration of injections by
unqualified personnel make injections unsafe [10].
Initiatives to reduce injection overuse
For safe injection practice, unnecessary injections should
be avoided. The National Drug Policy (1995) of Nepal
aims to promote rational use of medicine through regular
training and implementation of STS. There is a separate
subsection regarding “Prudent use of antibiotics” in the
policy (added by amendment in 2001), but there is still no
such section for injection use [22]. Almost half of the pol-
icymakers, especially in MoHP, were of the opinion that
the National Drug policy (NDP) of Nepal discourages in-
jection overuse, while others, including DDA authorities,
mentioned that the NDP does not directly discourage
injection overuse. This may be because national drug pol-
icy discussions could have been less extensive among
MoHP personnel who may be more concerned about the
overall National Health Policy.
Effective implementation of the essential medicine policy
and the STS/standard treatment guideline (STG) empha-
sizing the rational use of oral formulations rather than
injectable formulations also helps to check overuse [6].
Both the policy and schedule should be implemented
properly for better outcomes. Minimizing the number of
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the policymakers. As the EDL and STS have been imple-
mented in government health care facilities, the decrease
might have been limited to those health care facilities only.
Furthermore, the EDL was revised after 9 years in 2011
and the STS has not been revised during the last 15 years
[23]. Since 2010, the government of Nepal has imple-
mented a policy of making basic health services accessible
to the people and as a part of this policy [3], a few essen-
tial medicines are provided free of cost from government
health care facilities (up to district level hospitals). As this
list contains a reduced number of injections, policymakers
stated that the overuse of injections has been discouraged.
However, the authors are of the opinion that only decreas-
ing the number of injections in the EDL or decreasing the
supply may not be sufficient to decrease injection overuse,
because even if injections are not available in government
health care facilities, injection providers may provide
injections in their private clinics [15].
Initiatives for safe injection practice
Use of auto disable (AD) syringes for immunization
significantly decreases the disease burden due to unsafe
injection practices [12]. Using single-use disposal syringes
(especially AD syringes for immunization) and matching
the supply of injection equipment and diluents with the
delivery of injectable medicine and vaccines, as shared by
most policymakers, prevents reuse of injection equipment
and are important for safe injection practices. The match-
ing of injection equipment (including syringes) ensures
that the equipment is available continuously and in suffi-
cient quantity, which is a key determinant to ensure safe
injection practices [24]. Shortages of these devices lead
to their reuse [6,24,25] and promote unsafe injection
practices.
Increased demand for safe injections and for oral sub-
stitutes of injections could also be promoted through
educating people about the hazards of unsafe injections
[26]. Communicating the risk of HIV infection associ-
ated with injections to the general public and to health
care workers (HCWs), as shared by most policymakers,
is also important to ensure safe injection practices and
reduce unnecessary injections. However, the educational
interventions thus planned should not adversely affect
the demand for essential injections such as vaccines and
contraceptives.
Quality monitoring of injection equipment
Almost two-thirds of the policymakers reported that
there was no legally authorized body to check and con-
trol the quality of injection equipment in Nepal, while
other policymakers were either unaware of or lacked
clarity about the authority. In Nepal, most injection
devices are imported, with a majority coming from India[15] where illegal reuse and repacking of used syringes is
common [27,28]. Almost half the policymakers acknowl-
edged that illegal commercialization of used disposable
syringes exist in Nepal. Hence, there may be reason to
suspect the quality of the syringes available in the na-
tional market. The Guidelines of Regulation of Health
Related Products, as mentioned by a few high-level
authorities of MoHP, is expected to strengthen the quality
monitoring of health related products, including injection
equipment. Implementation of this guideline, which is still
at the drafting stage, is the need of the hour.
Disposal of used injection equipment
Use of safety boxes is important for the safety of injec-
tion providers. Studies have shown that a significant pro-
portion (5-28%) of NSIs are due to unsafe sharp waste
collection procedures [29,30] and use of safety boxes for
collection of sharp waste reduces the risk [31]. Hence, a
supply of safety boxes could be considered a positive
initiative towards safe injection practice.
In Nepal, certain policies and strategies have been
framed to address the management of general waste and
hospital waste. The most important of these were the
Health Care Waste Management Guidelines (2008/9)
and the Solid Waste Management Act (2011) [32]. The
Health Care Waste Management Guidelines (2008/9)
were regarded as an institutional waste management policy
by almost all policymakers, but the policy is not imple-
mented satisfactorily [32]. The guidelines have categorized
health care wastes and emphasized waste minimization,
segregation and proper disposal. They have also differenti-
ated the responsibilities of waste producers (health institu-
tions), local authorities and national-level hospitals [33].
The Solid Waste Management Act (2011) deals with the
management of all kinds of waste, including biomedical
waste. According to the act, the management of solid waste
(including biomedical waste) is the responsibility (legally
and financially) of the health care facilities [34]. The imple-
mentation of both the guideline and the act are poor [32].
The National Heath Policy, 1991 does not address medical
waste management, so the issue of medical waste manage-
ment and environmental health should be addressed in an
integrated manner [16] because proper sharp waste
management is crucial for safe injection practice [10].
Recommendations
Use of sterile injection equipment (syringes) for injections,
ensuring availability of safety boxes, formulating and im-
plementing guidelines and plans for disposal of used syrin-
ges, and educating the general public and HCWs about
the association between injections and infections through
HIV/AIDS prevention programmes (as stated by the pol-
icymakers in this study) could be initiatives to promote
safe injection practices. The use of AD syringes and safety
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services and government health institutions, should be
broadened. Lack of injection-related policies and the im-
proper implementation of guidelines and plans for health
care waste management may be considered as grey areas
for safe injection practice. Hence, policies and guidelines
to monitor the quality of injection equipment (includ-
ing syringes), restricting injection practice by unqualified
health care professionals and quacks, and safe and envir-
onment-friendly disposal of injection equipment is rec-
ommended. Furthermore, effective implementation and
regular updating of EDL and STG is required to reduce
injection overuse.
Limitations
To the best of our knowledge this is the first study in
Nepal conducted with the objective of obtaining the
perception of important policymakers about injection
practices in the country. The sample size was small and
though heads of important departments dealing with
injection safety in Nepal were included there is a possibil-
ity that the findings may not be fully representative of the
opinion of health policy makers and policy makers not in-
cluded in the study may have a different perspective. The
result may however, provide a platform for further studies.
Further studies that also include stakeholders from the
community may provide a clearer picture about the injec-
tion practice in Nepal. Repeat interviews with policymakers
could not be done due to time constraints. Instances of re-
call bias may have occurred among the participants.
Conclusions
Safe injection practice is a very important step toward
ensuring safe and effective healthcare. This study indi-
cates that the government of Nepal has attempted to
make injection practices safer, but these attempts seem
to be limited to immunization services and to govern-
ment health care facilities. The study also found a diver-
sity of views among policymakers about certain aspects
of safe injection practice in Nepal. Proper coordination
among policymakers and standardization of policies and
procedures related to injection practice are important
steps towards making injection practice safer. There is a
need of further community-based surveys to expand the
results of this study and to obtain a clearer picture of
injection practices in Nepal. This study will serve as a
platform for such surveys.
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